. . "In addition, the company continues to advance its global regulatory strategy and has filed Clinical Trial Applications in the Philippines and Thailand, as well as a request for a Voluntary Harmonization Procedure in Europe, which provides for the assessment of multinational clinical trial applications across several European countries, including Germany, France and Spain." . .